Regeneron Pharmaceuticals reported $660.5M in Selling and Administration Expenses for its fourth fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Selling And Administration Expenses Change
Abbvie ABBV:US USD 3.22B 86M
Agenus AGEN:US USD 18.1M 809K
Agios Pharmaceuticals AGIO:US USD 29.12M 859K
Alimera Sciences ALIM:US USD 9.86M 46K
Alnylam Pharmaceuticals ALNY:US USD 235.86M 65.88M
Amgen AMGN:US USD 1.47B 181M
AstraZeneca AZN:LN USD 3.35B 280M
Biogen BIIB:US USD 563.3M 9.3M
Biomarin Pharmaceutical BMRN:US USD 216.82M 19.98M
Bluebird Bio BLUE:US USD 33.4M 3.29M
Bristol Myers Squibb BMY:US USD 2.27B 336M
Eli Lilly And LLY:US USD 1.64B 29M
Esperion Therapeutics ESPR:US USD 24.95M 4.65M
Gilead Sciences GILD:US USD 2.02B 807M
GlaxoSmithKline GSK:LN GBP 2.44B 467M
Intercept Pharmaceuticals ICPT:US USD 43.27M 3.29M
Johnson & Johnson JNJ:US USD 6.51B 423M
Kyowa Hakko Kirin 4151:JP JPY 38.3B 559M
Merk MRK:US USD 2.63B 134M
Moderna Inc MRNA:US USD 278M 67M
Neurocrine Biosciences NBIX:US USD 186.3M 3.5M
Novartis NOVN:VX USD 3.4B 185M
Novartis NVS:US USD 3.7B 295M
Ophthotech OPHT:US USD 17.54M 1.44M
Opthea Ltd OPT:AU USD 18.44M 10.79M
Pfizer PFE:US USD 4.87B 1.33B
Puma Biotechnology PBYI:US USD 23.96M 3.38M
Regeneron Pharmaceuticals REGN:US USD 660.5M 131.4M
Roche Holding ROG:VX 5.64B 899M
Sarepta Therapeutics SRPT:US USD 104.79M 49.53M
Seattle Genetics SGEN:US USD 210.38M 9.88M
Teva Pharmaceutical TEVA:IT USD 777M 72M
Ultragenyx Pharmaceutical RARE:US USD 69.84M 1.7M
United Therapeutics UTHR:US USD 98.4M 43.1M
Vertex Pharmaceuticals VRTX:US USD 246.8M 31.5M
YTE INCY:US USD 266.46M 13.18M